Teva Pharmaceuticals to Attain End-to-End Supply Chain Visibility with Kinaxis
Kinaxis Inc, a leader in empowering people to make confident supply chain decisions, has announced it has been selected by Teva Pharmaceuticals to help Teva connect its data, processes and people into a single platform to transform its global supply chain, improve visibility and operational efficiencies and increase customer satisfaction.
Headquartered in Israel, with operations in 60 countries worldwide, Teva has the largest and most competitive fully integrated manufacturing and supply chain network in the industry. The company employs more than 43,000 people worldwide, producing approximately 2,400 products in nearly every therapeutic area. In 2018, Teva produced more than 100 billion tablets and capsules; every day, Teva touches the lives of approximately 200 million patients. SVP Global Supply Chain for Teva said: “Our goal is to improve lives and make better days for patients. With the world’s largest medicine cabinet, Teva makes treatment more accessible and affordable for millions of people worldwide.
“Being able to connect our entire supply chain, plan for multiple scenarios and understand the impact of potential changes in advance will help us deliver our products to customers and patients faster and more efficiently. The Kinaxis team’s proven knowledge of supply chain, their understanding of pharmaceutical business requirements and the maturity of their platform are clear indicators that they can help us realize significant value across our manufacturing operations and supply chain.”
Teva selected Kinaxis for its unique concurrent planning technique and advanced supply chain planning capabilities. With Kinaxis, Teva will gain greater visibility and control over its end-to-end supply chain network, collapse functional silos, increase collaboration, and more effectively balance inventory. Teva will benefit from capabilities such as integrated business planning, S&OP and advanced analytics for attribute-based planning, lot-for-lot management and product expiry monitoring.
CEO of Kinaxi John Sicard said: “When dealing with the health of millions of people, it is vital for everyone in the supply chain to be connected and working from the same information. This ensures you have the confidence that you are making the right decision at the right time.
“We are thrilled to have earned the trust of Teva, the leading generic pharmaceuticals company worldwide. We look forward to working with them to help reach their business objectives and improve the health of patients around the world.”
Kinaxis offers a robust cloud-based and attribute-based planning solution to help pharmaceutical companies incorporate complex planning rules, like those driven by the FDA. Using Kinaxis and concurrent planning to synchronize their supply chain functions, companies can more effectively manage product on a lot-for-lot basis. With intelligent, customisable product expiry monitoring, supply chain teams will be alerted when action on inventory is required to maximise customer service and ensure expiry dates are not surpassed to minimise extra cost.
About Kinaxis Inc
Eliminating volatility in your supply chain is impossible but managing it is not. Trusted by top brands, Kinaxis gives people the confidence to know they are making the best supply chain planning decisions to maximise business performance. We solve complex business problems in easy-to-understand ways by combining human and machine intelligence to plan for any future, monitor risks and opportunities and respond at the pace of change. With the support of our community of supply chain experts and using our unique concurrent planning technique and single integrated planning platform, customers can realize higher revenue, lower costs and fewer risks. For more Kinaxis news, please fill out the enquiry form attached to this page.